Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Jul 25, 2017 2:25pm
122 Views
Post# 26507170

RE:Completely agree with Lonade post

RE:Completely agree with Lonade post
harpos wrote: I wish I could toast with him and gaze at the Paris skyline. There are two things holding this price now. One is the thinking from idiots like Toad07 who wants to talk about PP and dilution. Only a complete fool would sell today. Sure, there is a possibility of a raise. There is a much greater possibility of a JV or a buyout. We have always recovered from a raise, if you try to time your sale and move out and wait for a pp, you may regret it the rest of your life. Is it worth the risk to try and get a better price when they may change oncology forever. Would you move out of Merck at 34 cents if you knew they had a strong possibility of curing bladder cancer. Like Lonade said, there has been talk of derisking this company before but now it is absolutely true. 
Remember PMH with its entire reputation at stake, approved every word of that PR.
RW would absolutely not commit to releasing data after the cystoscopes when I  asked him at the AGM,
because he had no idea that the data was this good. Not only did he not commit, he basically said they wouldn't because the trial would only be 90 days old. Clearly the ball was crushed out of the park and that changed everything. There results were better than everyone involved could have hoped for.

Agree with you either. 
When the rat result out, we hit 78 , while whit the epic result with human trial, we only got 44 cents, make no pharking sense.
Bullboard Posts